{"product_id":"ifitm3-antibody-sc-f2434","title":"Fragilis Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eIFITM3 is a target of interest in many antibody-based workflows. Bacteroides fragilis is a Gram-negative, anaerobic bacillus that serves a dual role in human health: it is an essential component of the gut microbiota and an opportunistic pathogen associated with endogenous infections, particularly intra-abdominal abscesses. While it contributes to gut health by aiding digestion and maintaining microbial balance, it can cause significant complications when the intestinal barrier is compromised due to surgery, trauma, or disease. Depending on the literature source, IFITM3 may also be discussed as Fragilis.\u003c\/p\u003e\u003cp\u003eReported cellular context includes cell membrane, cytoplasm, endosome, and lysosome, which can matter when signal is compared across treatments or changing cell states. Following IFITM3 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eIFITM3 is commonly interpreted in the context of infectious disease research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell membrane, cytoplasm, and endosome, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between cell membrane, cytoplasm, and endosome across matched conditions\u003c\/li\u003e\n\u003cli\u003ehost-response changes during infection or pathogen-associated stimulation\u003c\/li\u003e\n\u003cli\u003eco-patterning with orthogonal markers and control conditions that clarify pathway state\u003c\/li\u003e\n\u003cli\u003etime-matched comparisons so changes reflect biology rather than handling or sampling drift\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for IFITM3. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in IFITM3 reflect biology rather than handling. When interpreting IFITM3, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep IFITM3 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57577943466329,"sku":"F2434-20UL","price":139.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57577943499097,"sku":"F2434-100UL","price":329.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57577943531865,"sku":"F2434-2X100UL","price":489.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F2434-wb.gif?v=1773600398","url":"https:\/\/absource-diagnostics.myshopify.com\/products\/ifitm3-antibody-sc-f2434","provider":"Absource Diagnostics","version":"1.0","type":"link"}